Previous Article | Next Article 
Infection and Immunity, March 1999, p. 1405-1414, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Relationship between UDP-Glucose 4-Epimerase
Activity and Oligoglucose Glycoforms in Two Strains of
Neisseria meningitidis
Frank K. N.
Lee,1
Bradford W.
Gibson,2
William
Melaugh,3
Anthony
Zaleski,1 and
Michael
A.
Apicella1,*
Department of Microbiology, University of
Iowa, Iowa City, Iowa 52242,1 and
Department of Pharmaceutical Chemistry, School of
Pharmacy,2 and Department of
Chemistry,3 University of California
San
Francisco, San Francisco, California 94143-0446
Received 19 August 1998/Returned for modification 15 October
1998/Accepted 22 December 1998
 |
ABSTRACT |
Sodium dodecyl sulfate-polyacrylamide gel analysis of
lipooligosaccharide (LOS) from Neisseria meningitidis has
demonstrated considerable microheterogeneity in the variable region of
LOS due to the presence of novel glycoforms. As a step toward
understanding the basis for the expression of these novel
glycoforms, we have examined the LOS structures and
UDP-glucose 4-epimerase (epimerase) activity levels in
two strains (NMB and MA-1) and their respective galE
mutants. Strain NMB was found to have low epimerase activity and to contain multiple glycoforms, some of which appear to
contain only glucose sugars. The galE mutant had only
the oligoglucose glycoforms. Strain MA-1 had higher
epimerase activity at both log and stationary phases (2- and 12.5-fold, respectively) and one glycoform with a
putative lactosyl structure. Strain MA-1 galE had two
glycoforms that contained one or two glucose residues. To
understand the molecular basis for the different epimerase activities, we examined the predicted amino acid sequences of the
respective galE open reading frames and
determined the relative amounts of GalE protein. We found no
significant differences between the predicted amino acid
sequence of the GalE protein in NMB and that in MA-1. We observed no
significant differences in the level of GalE protein between MA-1 and
NMB at exponential or stationary phase. We also observed an
8.2-fold drop in epimerase activity in NMB between the log
and stationary phases that was not due to the GalE protein level or low
glucose levels.
 |
INTRODUCTION |
Pathogenic Neisseria
species are gram-negative obligate human pathogens.
Neisseria meningitidis, the causative agent of meningococcal meningitis, possesses a number of virulence factors. One of these virulence factors is the lipooligosaccharide (LOS). This molecule is
composed of a variable oligosaccharide portion and a conserved core-lipid A structure (1).
The assembly of the LOS molecule is a complex anabolic process
involving an array of biosynthetic enzymes including kinases, transferases, and isomerases. One of the isomerases is the UDP-glucose 4-epimerase (galactowaldenase, EC 5.1.3.2). This enzyme carries out the reversible epimerization of UDP-glucose to UDP-galactose, the
cognate substrate for galactosyltransferases. The Escherichia coli UDP-glucose 4-epimerase has been purified and studied
in detail at both the biochemical and the structural level. The
holoenzyme is a homodimer held together by hydrophobic interactions and
contains one NAD+ molecule per subunit (4).
The number of unique LOS species expressed by a meningococcal
strain can vary widely (24, 29). We have previously
reported on the LOS microheterogeneity of serogroup B
N. meningitidis NMB and its galE mutant
NMB-SS3 (14). The basis of this microheterogeneity was the
presence of three novel glycoforms that contained two to four
glucose residues. In the galE mutant NMB-SS3, only the oligoglucose glycoforms were detected, and the relative amounts of some of these novel glycoforms were significantly
increased compared to those in NMB. Also, in N. meningitidis MC58 galE, a second
glycoform with two glucose molecules was observed
(33). It is not known if the diglucose glycoform was
present in the parent strain. Pathogenic Neisseria species
cannot utilize exogenous sources of galactose, and thus the only source
of UDP-galactose is UDP-glucose. This suggests an important role for
UDP-glucose 4-epimerase in determining the UDP-glucose
and UDP-galactose concentrations and thereby perhaps influencing
the activity of cognate glycosyltransferases. In this report, we
present the LOS structures of MA-1 and its galE mutant MA-1
galE, and we compare the UDP-glucose 4-epimerase activity level of strain NMB to that of strain MA-1. We also present evidence demonstrating growth phase-dependent variation of
epimerase activity levels in NMB.
 |
MATERIALS AND METHODS |
Materials.
Chemicals and antibiotics were obtained from
Sigma Chemical Co. (St. Louis, Mo.). Restriction enzymes and
DNA-modifying enzymes were purchased from New England Biolabs, Promega
Co., and Boehringer Mannheim Biochemicals.
Bacterial strains and plasmids.
The bacteria and plasmids
used in this study are described in Table
1.
Growth of bacteria.
E. coli was grown at 37°C in
Luria-Bertani medium with or without 1.5% agar and supplemented with
antibiotics as needed. Wild-type N. meningitidis was
grown either on gonococcal agar with 1% IsoVitaleX supplement (BBL
Laboratories) or in brain heart infusion (BHI) broth supplemented with
2.5% heat-inactivated fetal calf serum and 1% IsoVitaleX.
Kanamycin-resistant N. meningitidis was grown on
supplemented BHI agar with 45 µg of kanamycin/ml or in supplemented BHI broth with 5 (for strain MA-1) or 25 (for strain NMB) µg of kanamycin/ml. N. meningitidis on agar plates was
cultured in the presence of 5% CO2 at 85% relative humidity.
Recombinant DNA and transformation methods.
All recombinant
DNA techniques were used as outlined elsewhere (23).
Transformations of N. meningitidis were performed as previously described by Catlin (4) and modified by Stephens et al. (25). Electroporations were carried out by using the GIBCO-BRL Cell-Porator under the recommended conditions.
DNA sequencing.
The nucleotide sequences of cloned genomic
DNA fragments were determined at the DNA Facility at the University of
Iowa by using an ABI373A automated sequencer.
Hybridizations.
Analyses of Southern blots were carried out
with radiolabelled random-primed probes at 65°C in 5× SSPE (1× SSPE
is 0.18 M NaCl, 10 mM NaH2PO4, and 1 mM
EDTA [pH 7.7]), 5× Denhardt's solution, 20 mM
Na3P2O7, 0.1% sodium dodecyl
sulfate (SDS), and 100 µg of heterologous DNA/ml. The filters were
washed twice at the hybridization temperature in 2× SSC (1× SSC is
0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% SDS for 15 min,
followed by two washes in 0.1× SSC and 0.1% SDS for 15 min. The
radioactive blots were exposed to Kodak XAR5 or BioMaxMR film at
70°C.
Hot-phenol LOS extraction.
LOS was purified from
N. meningitidis by a modified hot-phenol method
(34) as previously described (14). The purified LOS was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and
visualized by silver staining as described elsewhere (30).
Structural characterization of LOS.
To determine the effects
of UDP-glucose 4-epimerase activity on LOS biosynthesis, LOS
from the wild-type strain MA1 and a galE mutant were
partially characterized by mass spectrometry and composition analysis.
Crude LOS preparations (~1 mg each) from the two strains were first O
deacylated by treatment with hydrazine under mild conditions (37°C
for 30 min), followed by precipitation with chilled acetone
(10). For mass spectrometric analysis, O-deacylated LOS was
dissolved in a stock water solution (10 µg/µl) and analyzed by
matrix-assisted laser desorption ionization (MALDI) (7) and
electrospray ionization (ESI) (8) mass spectrometry as
previously described. For the MALDI analyses, several dilutions were
made of the original stock (1/10 to 1/100), and ~0.1 µg or less of
each O-deacylated LOS was added to 1 µl of a matrix solution of
2,5-dihydroxybenzoic acid (DHB) and spotted on a stainless-steel MALDI
sample plate. Mass spectra were taken on a PerSeptive Biosystems Voyager MALDI-time-of-flight mass spectrometer (PerSeptive Biosystems, Framingham, Mass.) fitted with a N2 laser operating at 337 nm. Typically, 50 to 100 single laser shots were averaged to obtain a
single spectrum by using a 100-ns delay time and a laser power setting
of 1,800 to 2,000. Spectra were smoothed (Savitsky-Golay procedure; 2 by 19 point) and externally calibrated with a close proximity standard
consisting of the commercial peptides bradykinin (Mavg = 1,060.2) and ACTH 1-24
(Mavg = 2,465.7). For ESI analyses, a stock solution
of each O-deacylated LOS preparation was diluted fivefold in
water-acetonitrile (1:1, vol/vol) containing 1% acetic acid to yield a
final O-deacylated LOS concentration of approximately 2 µg/µl. Five
microliters of each LOS sample was then injected via a Rheodyne valve
and analyzed in the negative-ion mode on a Sciex API 300 triple
quadrupole mass spectrometer (Perkin-Elmer SCIEX, Mississauga, Ontario,
Canada) with a flow rate of 3 to 4 µl/min. Mass calibration was
carried out with an external myoglobin reference by using the
commercial software supplied.
Monosaccharide composition analyses were carried out on O-deacylated
LOS preparations by two independent methods. For neutral sugar
analysis, aliquots of each O-deacylated LOS pool were hydrolyzed in 2 M
trifluoroacetic acid for 3 h at 100°C. Amino sugars were analyzed after hydrolysis in 6 N HCl for 3 h at 100°C. In both cases, aliquots of the final hydrolysates were evaporated to
dryness, redissolved in 20 µl H2O, dried, and then
reconstituted in water. A 5% aliquot (1 of 20 µl) of each
sample was analyzed by high pH anion-exchange chromatography by using a
Dionex high-pressure liquid chromatography system equipped with a PA1
column as previously described (20). To identify and
quantify the monosaccharides from each hydrolysate, a standard mixture
of monosaccharides containing equimolar amounts of fucose,
galactosamine, glucosamine, galactose, glucose, and mannose was
analyzed before and after each run.
Glucose supplement of stationary-phase culture.
A fresh
overnight culture of N. meningitidis NMB grown in
Morse's defined medium with 20 mM glucose (18) was used to
inoculate 50 ml of fresh medium and incubated at 37°C with shaking.
Aliquots (15 ml) were removed at mid-log and early-stationary phases,
and epimerase activities were determined. Glucose was added to
the remaining culture to a final concentration of 20 mM, and it
was incubated for one additional hour, after which the
epimerase activity was determined.
Purification of recombinant meningococcal GalE.
The NMB
galE open reading frame was cloned into plasmid pCYB2 of the
IMPACT Protein Purification System (New England Biolabs), and the
recombinant meningococcal GalE was purified according to the
manufacturer's recommendations. The purified protein was verified by
amino-terminal sequencing at the Protein Structure Facility, University
of Iowa.
Generation of polyclonal antibodies.
Mouse polyclonal
antibodies to recombinant meningococcal GalE were raised by coinjection
with the RIBI Adjuvant System (RIBI ImmunoChem Research, Inc.)
according to the manufacturer's recommendations. The ascites fluid was
harvested and assayed for reactivity to the purified antigen by
enzyme-linked immunosorbent assay.
SDS-PAGE and Western blot analysis.
Cultures of
N. meningitidis MA-1 and NMB were harvested and lysed
by sonication. Total protein concentrations were determined with the
Bio-Rad Protein Assay Reagent system, and equivalent amounts of total
protein were fractionated by 12.5% SDS-12.5% PAGE. The resolved
proteins were transferred to nitrocellulose under standard conditions
and reacted with mouse polyclonal antisera to recombinant meningococcal
GalE that had been preabsorbed with paraformaldehyde-fixed MA-1
galE. The reacting bands were visualized with a horseradish
peroxidase-conjugated anti-mouse immunoglobulin G secondary antibody
(Bio-Rad, Inc.) and the SuperSignal Horseradish Peroxidase Detection
System from Pierce Chemicals. The relative intensities of the
bands were estimated with Eastman Kodak (Rochester, N.Y.) 1D
Image Analysis Software.
Preparation of cell extract.
N. meningitidis
strains were grown in supplemented BHI broth with kanamycin as
required. For each strain, a 50-ml culture was inoculated with 0.01 volume of fresh overnight culture and incubated overnight at 37°C
with shaking. The washed pellets were resuspended in 2 ml of buffer
(0.125 M potassium bicinate [pH 8.5]-1 mM phenylmethylsulfonyl
fluoride) and lysed by sonication. The bacterial debris was pelleted by
centrifugation at 15,800 × g for 30 min at 4°C. The
supernatants were transferred to prechilled microcentrifuge tubes and
kept on ice. The total protein contents of the cleared cell extracts
were determined by using the Bio-Rad Protein Assay Reagent system
following the microassay protocol. Equal amounts of total protein were
added to the two-step UDP-glucose 4-epimerase assay as
described below.
Enzyme assays.
The standard UDP-glucose 4-epimerase
assays have been published elsewhere (35). We modified the
assay slightly to optimize it for meningococcal extracts. The first
step of the two-step assay was carried out in a 500-µl reaction
volume (0.125 M bicinate [pH 8.5]-0.45 mM UDP-galactose) at 37°C
for 15 min. The reaction mixture was then placed in a boiling water
bath for 90 s, chilled on ice for 5 min, and then centrifuged at
15,800 × g for 10 min at 4°C. A 400-µl aliquot of
the supernatant was added to the second step of the assay in 600 µl
(0.125 M bicinate [pH 8.5]-1.25 mM NAD+-0.02 U of
UDP-glucose dehydrogenase). The reaction mixture was incubated at room
temperature for 3 min in a methylacrylate cuvette, and the increase in
absorbance was measured at 340 nm at 15-s intervals. We were able to
achieve a twofold increase in sensitivity with the modifications
compared to that of the standard two-step method using the glycine
buffer. All extracts, including appropriate controls, were assayed in triplicate.
Determination of UDP-glucose 4-epimerase activity
levels.
The net absorbance was determined after adjustment for
endogenous UDP-galactose and UDP-glucose and for UDP-glucose
contamination of exogenous UDP-galactose preparations. The initial
velocities of the second reaction (UDP-glucose to UDP-glucuronic acid)
were determined over the first 30 s. This initial reaction
velocity (Vi) is a function of the initial
UDP-glucose concentration, which in turn is a function of the
UDP-glucose 4-epimerase activity level. These values were
converted to nanomoles of NADH generated per minute by using the
Beer-Lambert law and the equation
NADH = 6.2 × 103 · M
1 · cm
1.
The assay results were analyzed by paired t tests using the Statview program (Abacus Concepts).
Nucleotide sequence accession number.
The nucleotide
sequence the galE region of strain MA-1 is listed under
accession no. AF083467.
 |
RESULTS |
Analysis of LOS from MA-1 and MA-1 galE by
SDS-PAGE.
MA-1 LOS migrated faster than the major NMB LOS species
on SDS-PAGE analysis and did not appear to be sialylated (Fig.
1). The MA-1 LOS also migrated as a
single band, in contrast to NMB LOS. The MA-1 LOS also reacted
with monoclonal antibody 4C4, which recognizes Gal-Glc-Hep or Glc-Hep
structures (12) (data not shown).

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-PAGE analysis of LOS isolated from N. meningitidis MA-1 and NMB. This figure illustrates the multiple
glycoforms observed in NMB LOS due to variations in the
oligosaccharide or PEA composition and the apparent homogeneity of MA-1
LOS. Lanes 1 and 2, N. meningitidis NMB LOS (2.0 and
0.2 µg, respectively); lanes 3 and 4, N. meningitidis
MA-1 LOS (2.0 and 0.2 µg, respectively).
|
|
A 4.2-kb DraI fragment that contained the galE
gene and three other open reading frames was cloned from strain MA-1.
The last three open reading frames were identified as galE,
rfbB, and rfbA homologues. The first open
reading frame (ORF1) was identical to the recently reported
mynD (27). A FASTA search of the protein database
indicated that ORF1 (mynD) had the highest similarity to a
putative DNA-binding protein from yeast (P = 0.062 over
201 amino acids) (data not shown).
We placed a kanamycin cassette 647 bp into the galE open
reading frame and introduced the mutation into the chromosome by allelic replacement. A kanamycin-resistant transformant designated MA-1
galE was screened by Southern hybridization (Fig.
2a), SDS-PAGE analysis (Fig. 2b), and
epimerase enzyme assay (data not shown). The results confirmed
the insertion of the kanamycin cassette into the meningococcal
genome through allelic replacement, resulting in a significant
decrease in UDP-glucose 4-epimerase activity. SDS-PAGE
analysis of isolated MA-1 galE LOS indicated the presence of
two bands. The majority of the LOS molecules appeared to be the
expected truncated form, but there was a minor band which appeared to
comigrate with wild-type LOS (Fig. 2b).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of N. meningitidis MA-1
galE. (a) Southern blot analysis of genomic DNA from
N. meningitidis MA-1 galE. Genomic DNAs
isolated from N. meningitidis MA-1 and MA-1
galE were digested with DraI and transferred to a
nylon membrane after electrophoresis. Duplicate filters were probed
with either a galE gene probe (lanes 1 and 2) or a
kanamycin cassette probe (lanes 3 and 4). The hybridization patterns
indicated the incorporation of the kanamycin cassette in the
galE open reading frame. A genetic map of the N. meningitidis MA-1 galE mutant is shown below. The MA-1
galE gene was cloned on a 4.2-kb DraI fragment.
This fragment had four open reading frames, as designated. To construct
MA-1 galE, a kanamycin cassette from pBSL14 was inserted
into the unique MunI site 647 bases into the galE
coding region. This construct was introduced into the
chromosome of MA-1 by allelic replacement. Open arrows, meningococcal
open reading frames; solid arrow, kanamycin resistance cassette. (b)
SDS-PAGE analysis of MA-1 and MA-1 galE LOS. The wild-type
LOS migrated as a single band. The LOS from the galE mutant
gave two distinct bands, of which the upper band comigrated with the
wild-type LOS molecule. The lower band is the
Hex-Hep2-GlcNAc-Kdo2-lipid A structure.
Lanes 1 and 2, MA-1 LOS (2.0 and 0.2 µg, respectively); lanes 3 and 4, MA-1 galE LOS (2.0 and 0.5 µg,
respectively).
|
|
Genetic analysis of the MA-1 galE gene.
The
organization of the 4.2-kb fragment suggested that the MA-1
galE gene was within an operon, perhaps contiguous with the previously described myn operon (27). We
introduced a kanamycin cassette in polar and nonpolar orientations
upstream of the galE open reading frame at two different
sites (Fig. 3). Analysis of these mutants
by epimerase enzyme assay and SDS-PAGE of their LOS (Table
2) indicated that the presence of polar
insertions at EcoRI and NdeI sites (RKR and NKR,
respectively) abrogated the expression of the galE gene.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
Positions and orientations of the kanamycin cassette
(solid lines with arrows) in the region upstream of the galE
open reading frame. The positions of the restriction sites are given
relative to the galE gene start codon. Open arrows, open
reading frames. RKR and NKR, polar insertions of the kanamycin cassette
at the EcoRI and NdeI sites, respectively. RKF
and NKF, respective nonpolar insertions.
|
|
The promoter for the galE gene of a serogroup B
strain, B1940, has been mapped previously (9). The
nucleotide sequence upstream of the NMB galE gene
is identical to the sequence from B1940 (data not shown).
ESI mass spectrometric analysis of LOS isolated from
N. meningitidis MA-1 and MA-1
galE.
Mass spectrometric analyses of the O-deacylated LOS
preparations from the wild-type strain, MA-1, and the galE
mutant are shown in Fig. 4 for the
corresponding MALDI spectra. For the wild-type strain, N. meningitidis MA-1, two prominent, singly deprotonated molecular-ion species were identified in the high-mass range (m/z >2,000) with m/z values of (M
H)
= 2,428.0 and 2,551.1, as well as peaks related to these two major
species through either loss of water (
18 Da),
-elimination of
phosphoric acid (
98 Da), or noncovalent addition of one or more
sodium (+22 Da) or magnesium (+38 Da) ions or both. As shown in Table
3, these masses are consistent with a LOS
composition of a Hep2-HexNAc-2 molecules of
3-deoxy-D-manno-octulosonic acid (Kdo2)-lipid A core structure substituted with two
hexoses (galactose and glucose) and containing either one (LOS B; M
calculated 2,428.2) or two (LOS B'; M calculated 2,551.3)
phosphoethanolamine (PEA) groups (
M = 123 Da).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
Negative-ion MALDI-time-of-flight mass spectra of
O-deacylated LOS preparations of wild-type MA-1 (A) and MA-1
galE (B).
|
|
The MALDI spectra of the galE mutant LOS were markedly
different from those of the wild-type MA-1 LOS. In the former case, the
two most abundant molecular-ion species were seen at
m/z~2,265 and 2,388, approximately 1 hexose lower in mass
(i.e., Hex = 162 Da) than the two base peaks in the wild-type MA-1
MALDI spectra. However, peaks corresponding to the two wild-type
molecular ions at m/z ~2,427 and 2,551 were also present
in the mutant LOS preparations, but at considerably lower abundances.
Electrospray analysis of the mutant and wild-type LOS preparations (see
Table 3) also supported these assignments, containing both doubly and
triply charged ions for the LOS A and B glycoforms (with and
without the additional PEA) for the mutant, and primarily the two LOS B
glycoforms in the wild type.
In addition to the prominent molecular-ion regions of these two
spectra, the low-mass regions of the two MALDI spectra (m/z <1,600) contained ions whose relative abundance was dependent on
the laser power. As reported previously (7), these
ions are "prompt fragments" and are generated primarily from
cleavage at the Kdo glycosidic bond to the lipid A moiety. Figure
5 shows the likely fragmentation pathways
for these ions for MA-1, which give additional support for the
assignment of the major glycoform species. For example,
in the MA-1 spectra the peak at m/z 951.7 would
correspond to the deprotonated lipid A species containing two phosphate
groups. The small peak at m/z 1,031.7 suggests that a
triphosphoryl lipid A species is also present, but at a much lower
abundance (<10%) than the dominant diphosphoryl lipid A form. The
peaks at m/z 1,597.0 and 1,473.8 can be assigned as originating from the same cleavage but with charge retention on the
oligosaccharide fragments, which can undergo further fragmentation due
to losses of 44 Da (
CO2; m/z 1,552.9 and
1,429.8) and 220 Da for the terminal Kdo moiety (m/z 1,376.7
and 1,254.0). An analogous set of assignments can be made for the
galE strain; although in addition to the fragments arising
from the less-abundant LOS B glycoforms as just described, ions
are seen for the oligosaccharide fragments of the LOS A
glycoforms that are now shifted down in mass by 1 hexose unit
(
162 Da).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
Fragmentation pathways of the two prominent singly
charged ions corresponding to the LOS B and LOS B' glycoforms.
All masses are calculated masses. See the spectra (Fig. 4) for the
actual experimental masses.
|
|
Composition analysis clearly supported the loss of galactose as
underlying the shift in mass (MALDI spectra) and faster migration (SDS-PAGE) of galE LOS. As shown in Fig.
6, the MA-1 wild-type LOS
preparation contained glucosamine (from the lipid A and
oligosaccharide regions), galactose, and glucose (oligosaccharide
branch). In contrast, the MA-1 galE mutant had significantly
reduced levels of galactose, which was barely detectable. Both MA-1
and MA-1 galE LOS preparations had residual amounts of
mannose. The mannose appears to be a contaminant in the LOS, since
multiple washes of the LOS result in its removal.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Composition analysis of MA-1 (A) and MA-1
galE (B) under trifluoroacetic acid conditions, compared
with standard mixture (profile C) containing galactosamine (peak
1), glucosamine (peak 2), galactose (peak 3), glucose (peak 4), and
mannose (peak 5). The conserved core Kdo is destroyed under the
hydrolysis conditions; the
L-glycerol-D-manno-heptose
peaks are not shown and elute much later (t > 25 min)
under the gradient conditions (see Materials and Methods).
|
|
Comparison of GalE activity in N. meningitidis
MA-1 and NMB.
The epimerase activity levels in MA-1 and
NMB at the exponential and stationary phases were measured by the
two-step assay. At the exponential phase, there was a twofold
difference in the epimerase activity level between MA-1
and NMB (Table 4). In
stationary-phase cultures, there was a 12.5-fold difference in the
enzyme activity levels. This difference was not due to an increase in
enzyme activity in MA-1, but rather to an 8.2-fold decrease in NMB
epimerase activity from the exponential to the stationary
phase. N. meningitidis MA-1 had similar activity levels
at both phases of growth. The addition of 20 mM glucose to a
stationary-phase culture of strain NMB did not increase the
epimerase activity (1.7 ± 0.3 versus 2.7 ± 0.5 nmol
of NADH generated per min [means ± standard errors] for NMB
with and without glucose, respective; P = 0.0377).
Comparison of predicted GalE amino acid sequences.
We cloned
the galE genes from N. meningitidis MA-1 and
NMB and compared the predicted amino acid sequences of the
galE open reading frames alongside that of the previously
cloned FAM20 galE gene (14). There was a high
degree of identity among the putative NAD+ and UDP-sugar
binding site residues (28) (mean = 95.65%; 22 of 23 amino acids) and 91% identity over the entire length of the
polypeptide. There was one binding site residue change at amino acid
300 (F in MA-1, S in NMB, and F in FAM20) (Fig.
7). The corresponding residue is a
tyrosine (position 299) in the E. coli GalE
polypeptide, and this amino acid is not conserved among the other
GalE proteins of gram-negative bacteria. In contrast, other
binding site residues are highly conserved between meningococcal GalE
and the E. coli GalE protein. Protein secondary-structure analysis indicated a high degree of conservation in the first 290 residues between MA-1 and NMB GalE polypeptides. This observation is
consistent with the predicted amino acid sequence, where the first 290 residues are highly conserved (97.24% identity) and the last 49 residues are less conserved (75.51% identity). The last 49 residues contain 3 of the 21 active-site residues.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 7.
Predicted amino acid alignment of GalE proteins from
various gram-negative bacteria. The consensus sequence is shown at the
bottom. The meningococcal polypeptide is 1 amino acid longer than the
protein from gonococci, Haemophilus influenzae, or E. coli. According to the structural data from the E. coli
epimerase (3, 17, 26, 28), the amino acids that form
the binding pockets of NAD+ and UDP-sugar are boldfaced.
The amino acids that form hydrogen bonds with NAD+ are
italicized, and those bonding with UDP-sugar are underlined. The
residues involved in binding of both the cofactor and the substrate are
italicized and underlined. S124 and Y149 of the E. coli
protein are critical for catalysis, and these residues are conserved in
both prokaryotes and eukaryotes. Nmn, N. meningitidis,
Ngc, Neisseria gonorrhoeae; H. influ, H. influenzae.
|
|
Analysis of UDP-galactose epimerase activity in
galEt deletion mutants of strains MA-1 and NMB.
The
meningococcal genome contains a second partially duplicated copy of the
galE gene (9, 11, 14, 15) that is not present in
the gonococcal genome. This second copy is a duplication of the
last 621 bp of the full-length open reading frame and contains one of
the two putative hydrophobic domains involved in homodimer formation
(3). To determine the contribution of the duplicated galE gene to the UDP-glucose 4-epimerase activities
in strains MA-1 and NMB, all but the first 20 bp of the second
galE open reading frame was deleted and replaced with a
kanamycin cassette from pBSL14 (1). The deletion was
introduced into the chromosomes of N. meningitidis MA-1
and NMB by transformation. Kanamycin-resistant transformants were
screened by Southern blot hybridization and SDS-PAGE analysis of LOS
(data not shown).
Crude cell extracts from cultures of wild-type MA-1 and NMB and their
galEt::npt mutants at exponential
and stationary phases were prepared, and epimerase activity
levels were measured. For both MA-1 and NMB, the UDP-glucose
4-epimerase activity levels were not significantly different in
the wild type and the
galEt::npt mutant at exponential phase (Table 4). The growth curves
of the wild-type and
galEt::npt
strains were identical (data not shown). The deletion of the
galEt gene in MA-1 had no significant effect on
epimerase activity at stationary phase. In NMB there was a 2.5-fold increase in enzyme activity in the mutant compared to the wild
type at stationary phase (Table 4). The removal of the galEt
gene was not able to restore the 8.2-fold decrease in NMB epimerase activity between the exponential and stationary phases.
Western blot analysis of wild-type meningococcal strains.
We
analyzed whole-cell extracts from wild-type N. meningitidis MA-1 and NMB with polyclonal antisera in order to
determine the amounts of GalE protein in the respective strains at the
exponential and stationary phases. We detected a band that was specific
to the GalE protein which was not present in the extract prepared from
MA-1 galE. The Western blot analysis indicated that there were equivalent amounts of the GalE protein in N. meningitidis MA-1 and NMB at exponential phase. Similarly, at
stationary phase, the amounts of GalE protein in MA-1 and NMB appeared
to be equivalent. Within NMB, there was a slight increase in the amount
of GalE protein at stationary phase compared to exponential phase. A
similar observation was made in strain MA-1 (Fig.
8). Compared to the normalized band
intensity of NMB GalE at log phase (taken as 1.0), the band intensity
of NMB GalE at stationary phase was 1.3 (P = 0.0099),
that of MA-1 GalE at log phase was 1.0 (P = 0.4639 for
MA-1 GalE versus NMB GalE at log phase), and that of MA-1 GalE at
stationary phase was 1.8 (P = 0.0025 for MA-1 GalE at log phase versus stationary phase; P = 0.1296 for MA-1
GalE versus NMB GalE at stationary phase). These values are means of
three calculations.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 8.
Western blot analysis of meningococcal whole-cell
lysates. Bacteria at either the exponential (lanes 2 and 4) or the
stationary (lanes 3 and 5) phase were harvested and lysed by
sonication. The protein concentrations were determined, and equal
amounts of protein were loaded. The Western blots were incubated with
preabsorbed mouse polyclonal antisera to recombinant meningococcal GalE
protein. Lane 1, purified recombinant GalE; lanes 2 and 3, N. meningitidis NMB; lanes 4 and 5, N. meningitidis MA-1; lane 6, MA-1 galE. Solid arrowheads
denote the band specific to GalE.
|
|
 |
DISCUSSION |
To further understand the role of UDP-glucose 4-epimerase
in the biosynthesis of oligoglucose glycoforms found in
meningococcal LOS, we examined the LOS from strain MA-1 and its
galE mutant by mass spectrometry. We compared the results
from these studies with the structure of LOS from NMB and
NMB-SS3, which we had previously characterized
(14). We also examined the epimerase activity levels in MA-1 and NMB at the log and stationary phases of growth. The
LOS of MA-1 was composed of one glycoform with one or two PEA
groups. The MA-1 galE LOS had two glycoforms
with either one or two glucose residues and PEA substituted
for HepII. The UDP-glucose 4-epimerase assay
indicated a twofold difference in epimerase activity at log
phase and a 12.5-fold difference at stationary phase between MA-1 and
NMB (Table 3). Recently, Wakarchuk et al. (33) reported the
presence of a glycoform with a diglucose structure in their
galE strain. Pathogenic Neisseria species do not
possess the accessory enzymes required for the utilization of exogenous
galactose. This implies that UDP-glucose 4-epimerase is
involved in controlling the ratio of UDP-galactose to
UDP-glucose. The meningococcal epimerase, like the
epimerases from yeast and E. coli, has an
equilibrium constant favoring the formation of UDP-glucose
(14). These observations suggest that the oligoglucose
glycoforms in strain NMB and the absence of these glycoforms in strain MA-1 may be linked to the level of
UDP-glucose 4-epimerase activity in the respective strains. The
presence of the oligoglucose glycoforms in NMB-SS3 and the
diglucose LOS structure in MA-1 galE and MC58
galE further support this interpretation.
The oligoglucose glycoforms in NMB-SS3 had up to two
additional glucose molecules, while the oligoglucose glycoforms
in MA-1 galE had one additional glucose. Similarly,
MC58 galE had a novel glycoform containing an
additional glucose (33). The transfer of the additional
glucose residue(s) could occur by one of two pathways. The
increased UDP-glucose concentration could either activate an
unidentified glucosyltransferase or induce its expression. Alternatively, in the absence of UDP-galactose, galactosyltransferase could use UDP-glucose as a substrate. Based on our observations and
that of Wakarchuk et al. (33), the first glucose residue after the Glc-HepI core structure could be added by the
LgtE protein, a galactosyltransferase. The detection of the
tetraglucose glycoform in NMB and NMB-SS3 suggests that the
addition of the last two glucose residues to the core Glc-Hep structure
in NMB may have been performed by a second glucosyltransferase, perhaps
the recently identified glycosyl transferase, LgtG (2). This
conclusion is supported by the observation that NMB LOS has a glucose
residue attached to HepII through an
1-3 linkage in
addition to the conserved N-acetylglucosamine (6,
22). These observations suggest that the appearance of the
oligoglucose glycoforms in NMB but not in MA-1 may be a
combinatorial effect of low UDP-glucose 4-epimerase activity
and the presence of a second glucosyltransferase activity. This gene
does not appear to be present in the genome of serogroup A
meningococci. Recently, Kahler et al. (13) identified the
lgtF locus in strain NMB. An LgtF
strain did
not contain any detectable levels of glucose, suggesting that LgtF is
responsible for adding the glucose to HepI. The second
glucosyltransferase activity (GlcII to HepII;
LgtG) requires the presence of the first glucose residue on HepI, analogous to the Kdo-dependent acyltransferases
in E. coli lipid A biosynthesis (21).
Recently, further analysis of LOS from strain NMB was reported by
Rahman et al. (22). They were unable to detect
oligoglucose glycoforms in the LOS prepared from
wild-type NMB. The detection of oligoglucose glycoforms
in LOS preparations from galE strains of NMB, MA-1, and MC58
(14, 15, 33) suggests that they may be present in the
wild type, albeit at low levels, perhaps below the detector
sensitivity. It is also possible that different culture conditions led
to differential expression of various LOS glycoforms. Such
observations have been previously reported by other investigators (19, 29).
The putative structure of LOS from strain MA-1 was determined as
Gal-Glc-Hep2-GlcNAc-Kdo2-lipid A based on
ESI-mass spectrometric analysis. The absence of a sialylated derivative
is consistent with the absence of sialic acid biosynthesis genes in
serogroup A meningococci (16). Serogroup A strains are
characterized by an (
1-6)-linked
N-acetylmannosamine-1-phosphate capsule (16), rather than the sialic acid-containing capsules associated with other
serogroups. It is interesting that the galE gene and the genes for production of the
N-acetylmannosamine-1-phosphate capsule appear to be
linked on the same operon. Indeed, polar insertion of a kanamycin
marker into our ORF1 resulted in barely detectable levels of
epimerase activity. This is not the organization found in
serogroup B or C, where the capsule biosynthesis genes and the
galE gene are separated by more than 1,000 nucleotides
(5). Based on comparison of the nucleotide sequences
upstream of galE genes from strains of serogroup B
(B1940) and C (FAM20), it appears that the NMB galE gene is
transcribed from its own promoter. The significance of this observation
is not clear at the moment, but further investigation may yield
explanations for the organization of these genes as a potential operon
in serogroup A meningococci. The residual epimerase activity
detected in MA-1 RKR and MA-1 galE was not statistically
significant compared to that in MA-1 NKR. The high epimerase
activity in MA-1 NKF is likely due to expression from the promoter for
the kanamycin cassette.
The UDP-glucose 4-epimerase activity levels varied between MA-1
and NMB by as much as 12.5-fold in stationary cultures and as little as
2-fold in exponential cultures. This is the first report we are
aware of documenting strain variability in the activity level of an
enzyme important for the virulence of pathogenic
Neisseria species. The UDP-galactose is not only used in LOS
biosynthesis but also serves as the galactose donor in glycosylation of
the pilin subunit of N. meningitidis (32).
Although many LOS biosynthesis genes have been cloned and mutated, the
regulation or strain variability of gene expression has not been
observed, with the exception of the meningococcal rfaC gene
(36). Our evidence strongly suggests that UDP-glucose
4-epimerase activity in N. meningitidis is
different in different strains. In strain NMB, differences in
epimerase activity were also observed between phases of growth.
The strain variability of epimerase activity could be due to a
number of factors. The respective epimerases could be
structurally different or could have different residues at the binding
sites for the cofactor and substrate. This appears unlikely, since the putative active-site amino acids are nearly identical in the
meningococcal GalE proteins (Fig. 7). It is also possible that the
genes could be transcribed, or that galE mRNA could be
translated, at different rates. In strain NMB, the galE
gene appears to be the first gene of an operon containing
rfb homologues, whereas in MA-1 (Fig. 2a), it is likely the
fifth gene of a large operon containing the myn genes
(27). We had noticed that the region immediately upstream of
the NMB galE open reading frame start codon is very thymidine rich, whereas the corresponding region in front of the MA-1
galE gene has a few more adenines (Fig.
9). The 3' end of the meningococcal 16S
rRNA is purine rich, containing mostly guanines. The minor differences
in the putative ribosome binding sites of the MA-1 and NMB
galE genes do not appear to be biologically significant, since the difference in the relative amount of GalE protein between the
strains at the exponential or stationary phase was not statistically significant.

View larger version (8K):
[in this window]
[in a new window]
|
FIG. 9.
Comparison of the nucleotide sequences of the region
upstream of the galE open reading frame start codon in MA-1
and NMB. The sequence of the 3' end of the meningococcal 16S rRNA is
shown below for comparison.
|
|
In addition to the strain differences in epimerase activity, we
observed an 8.2-fold decrease in enzyme activity in NMB between the two
sampling time points. This difference was not due to the NMB GalE
protein level at stationary phase, which was significantly higher than
the protein level at exponential phase. This suggested the presence of
a putative inactive enzyme at stationary phase. The putative inactive
enzyme did not appear to involve a defective GalE protein from the
second partial galE gene, since its deletion in NMB,
although it resulted in a slight increase in the epimerase activity level, did not restore the stationary-phase epimerase activity to the exponential-phase level. Previously, the expression of
the partial galE gene was not observed in Northern blot
analysis (9). Similarly, our results suggest that the
expression of the partial galE gene is minimal. These
observations suggest a mechanism other than regulation of expression or
defective dimer formation as a possible explanation for the low
epimerase activity at stationary phase in strain NMB. Such a
mechanism may be the formation of abortive enzyme complexes. Abortive
UDP-glucose 4-epimerase complexes have been detected in
E. coli (31). They are homodimers of
full-length GalE protein that contain NADH and a uridine nucleotide (usually UTP) instead of NAD+ and UDP-sugar. It is possible
that the physiological conditions in stationary-phase NMB favored
abortive epimerase formation. The enzyme activity level
was not dependent on the amount of glucose in the culture medium
at stationary phase.
In this report we demonstrated that the absence of UDP-glucose
4-epimerase activity resulted in the expression of detectable levels of diglucose glycoforms in strain MA-1. Additionally,
the level of epimerase activity may influence the expression of
oligoglucose glycoforms in strain NMB. We also demonstrated the
strain variability and growth phase-dependent variability of
UDP-glucose 4-epimerase activity in meningococci. Based on our
investigation, the difference in epimerase enzyme activity at
the exponential and stationary phases appears not to be linked to the
level of GalE protein. In strain NMB, the low epimerase
activity may be due to allosteric inhibition through the
formation of abortive epimerase complexes. Further
biochemical analysis of UDP-glucose 4-epimerase from
stationary-phase cultures of NMB is required to determine the nature of
the putative abortive epimerase complexes. We do not know if
the oligoglucose glycoforms are assembled throughout growth
phase at a constant rate or assembled predominantly at late stages of growth.
 |
ACKNOWLEDGMENTS |
This research was supported in part by NIH grants AI18384
and AI38515 to M.A.A. and AI31254 to B.W.G. The mass spectrometry was
performed at the UCSF Mass Spectrometry Facility, which is partially supported by a grant from the National Center for Research Resources (NCRR BRTP 01614).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 3-401 Bowen
Sciences Building, Department of Microbiology, College of Medicine,
University of Iowa, 51 Newton Rd., Iowa City, IA 52242. Phone: (319)
335-7807. Fax: (319) 335 9006. E-mail:
michael-apicella{at}uiowa.edu.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Alexeyev, M. F.
1995.
Three kanamycin resistance gene cassettes with different polylinkers.
BioTechniques
18:52-55.
|
| 2.
|
Banerjee, A.,
R. Wang,
S. N. Uljohn,
P. A. Rice,
E. C. Gotschlich, and D. C. Stein.
1998.
Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae.
Proc. Natl. Acad. Sci. USA
95:10872-10877[Abstract/Free Full Text].
|
| 3.
|
Bauer, A. J.,
I. Rayment,
P. A. Frey, and H. M. Holden.
1992.
The molecular structure of UDP-galactose 4-epimerase from Escherichia coli determined at 2.5 A resolution.
Proteins
12:372-381[Medline].
|
| 4.
|
Catlin, B. W.
1960.
Transformation of Neisseria meningitidis by deoxyribonucleates from cells and from culture slime.
J. Bacteriol.
79:579-590[Free Full Text].
|
| 5.
|
Frosch, M.,
C. Weisgerber, and T. F. Meyer.
1989.
Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B.
Proc. Natl. Acad. Sci. USA
86:1669-1673[Abstract/Free Full Text].
|
| 6.
|
Gamian, A.,
M. Beurret,
F. Michon,
J. R. Brisson, and H. J. Jennings.
1992.
Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.
J. Biol. Chem.
267:922-925[Abstract/Free Full Text].
|
| 7.
|
Gibson, B. W.,
J. J. Engstrom,
C. M. John,
W. Hines, and A. M. Falick.
1997.
Characterization of bacterial lipooligosaccharides by delayed extraction matrix-assisted laser ionization time-of-flight mass spectrometry.
J. Am. Soc. Mass Spectrom.
8:645-658.
|
| 8.
|
Gibson, B. W.,
W. Melaugh,
N. J. Phillips,
M. A. Apicella,
A. A. Campagnari, and J. M. Griffiss.
1993.
Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.
J. Bacteriol.
175:2702-2712[Abstract/Free Full Text].
|
| 9.
|
Hammerschmidt, S.,
C. Birkholz,
U. Zahringer,
B. D. Robertson,
J. van Putten,
O. Ebeling, and M. Frosch.
1994.
Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis.
Mol. Microbiol.
11:885-896[Medline].
|
| 10.
|
Helander, I. M.,
B. Lindner,
H. Brade,
K. Altmann,
A. A. Lindberg,
E. T. Rietschel, and U. Zahringe.
1988.
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69Rd/b+.
Eur. J. Biochem.
177:483-492[Medline].
|
| 11.
|
Jennings, M. P.,
P. van der Ley,
K. E. Wilks,
D. J. Maskell,
J. T. Poolman, and E. R. Moxon.
1993.
Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis.
Mol. Microbiol.
10:361-369[Medline].
|
| 12.
|
John, C. M.,
J. M. Griffiss,
M. A. Apicella,
R. E. Mandrell, and B. W. Gibson.
1991.
The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides.
J. Biol. Chem.
266:19303-19311[Abstract/Free Full Text].
|
| 13.
|
Kahler, C. M.,
R. W. Carlson,
M. M. Rahman,
L. E. Martin, and D. S. Stephens.
1996.
Two glycosyltransferase genes, lgtF and rfaK, constitute the lipooligosaccharide ice (inner core extension) biosynthesis operon of Neisseria meningitidis.
J. Bacteriol.
178:6677-6684[Abstract/Free Full Text].
|
| 14.
|
Lee, F. K.,
D. S. Stephens,
B. W. Gibson,
J. J. Engstrom,
D. Zhou, and M. A. Apicella.
1995.
Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB.
Infect. Immun.
63:2508-2515[Abstract].
|
| 15.
|
Lee, F. K. N.
1998.
Ph.D. thesis.
The University of Iowa, Iowa City.
|
| 16.
|
Liu, T.-Y.,
E. C. Gotschlich,
E. K. Jonssen, and J. R. Wysocki.
1971.
Studies on the meningococcal polysaccharides. 1. Composition and chemical properties of the group A polysaccharide.
J. Biol. Chem.
246:2849-2858[Abstract/Free Full Text].
|
| 17.
|
Liu, Y.,
J. B. Thoden,
J. Kim,
E. Berger,
A. M. Gulick,
F. J. Ruzicka,
H. M. Holden, and P. A. Frey.
1997.
Mechanistic roles of tyrosine 149 and serine 124 in UDP-galactose 4-epimerase from Escherichia coli.
Biochemistry
36:10675-10684[Medline].
|
| 18.
|
Morse, S. A., and L. Bartenstein.
1980.
Purine metabolism in Neisseria gonorrhoeae: the requirement for hypoxanthine.
Can. J. Microbiol.
26:13-20[Medline].
|
| 19.
|
Morse, S. A.,
C. S. Mintz,
S. K. Sarafian,
L. Bartenstein,
M. Bertram, and M. A. Apicella.
1983.
Effect of dilution rate on lipopolysaccharide and serum resistance of Neisseria gonorrhoeae grown in continuous culture.
Infect. Immun.
41:74-82[Abstract/Free Full Text].
|
| 20.
|
Phillips, N. J.,
C. M. John,
L. G. Reinders,
B. W. Gibson,
M. A. Apicella, and J. M. Griffiss.
1990.
Structural models for the cell surface lipooligosaccharides of Neisseria gonorrhoeae and Haemophilus influenzae.
Biomed. Environ. Mass Spectrum.
19:731-745[Medline].
|
| 21.
|
Raetz, C. R. H.
1996.
Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed, vol. 1. ASM Press, Washington, D.C.
|
| 22.
|
Rahman, M. M.,
D. S. Stephens,
C. M. Kahler,
J. Glushka, and R. W. Carlson.
1998.
The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent.
Carbohydr. Res.
307:311-324[Medline].
|
| 23.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 24.
|
Schneider, H.,
T. L. Hale,
W. D. Zollinger,
R. C. Seid, Jr.,
C. A. Hammack, and J. M. Griffiss.
1984.
Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis.
Infect. Immun.
45:544-549[Abstract/Free Full Text].
|
| 25.
|
Stephens, D. S.,
C. F. McAllister,
D. Zhou,
F. K. Lee, and M. A. Apicella.
1994.
Tn916-generated, lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae.
Infect. Immun.
62:2947-2952[Abstract/Free Full Text].
|
| 26.
|
Swanson, B. A., and P. A. Frey.
1993.
Identification of lysine 153 as a functionally important residue in UDP-galactose 4-epimerase from Escherichia coli.
Biochemistry
32:13231-13236[Medline].
|
| 27.
|
Swartley, J. S.,
L.-J. Liu,
Y. K. Miller,
L. E. Martin,
S. Edupuganti, and D. S. Stephens.
1998.
Characterization of the gene cassette required for biosynthesis of the ( 1 6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis.
J. Bacteriol.
180:1533-1539[Abstract/Free Full Text].
|
| 28.
|
Thoden, J. B.,
P. A. Frey, and H. M. Holden.
1996.
Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: implications for the catalytic mechanism.
Biochemistry
35:5137-5144[Medline].
|
| 29.
|
Tsai, C. M.,
R. Boykins, and C. E. Frasch.
1983.
Heterogeneity and variation among Neisseria meningitidis lipopolysaccharides.
J. Bacteriol.
155:498-504[Abstract/Free Full Text].
|
| 30.
|
Tsai, C. M., and C. Frasch.
1981.
A sensitive silver stain for detecting lipooligosaccharide in polyacrylamide gels.
Anal. Biochem.
199:115-119.
|
| 31.
|
Vanhooke, J. L., and P. A. Frey.
1994.
Characterization and activation of naturally occurring abortive complexes of UDP-galactose 4-epimerase from Escherichia coli.
J. Biol. Chem.
269:31496-31504[Abstract/Free Full Text].
|
| 32.
|
Virji, M.,
E. Stimson,
K. Makepeace,
A. Dell,
H. R. Morris,
G. Payne,
J. R. Saunders, and E. R. Moxon.
1996.
Posttranslational modifications of meningococcal pili. Identification of a common trisaccharide substitution on variant pilins of strain C311.
Ann. N. Y. Acad. Sci.
797:53-64[Abstract].
|
| 33.
|
Wakarchuk, W.,
A. Martin,
M. P. Jennings,
E. R. Moxon, and J. C. Richards.
1996.
Functional relationships of the genetic locus encoding the glycosyltransferase enzymes involved in expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis.
J. Biol. Chem.
271:19166-19173[Abstract/Free Full Text].
|
| 34.
|
Westphal, O., and K. Jann.
1965.
Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure.
Methods Carbohydr. Chem.
5:83-91.
|
| 35.
|
Wilson, D. B., and D. S. Hogness.
1969.
The enzymes of the galactose operon in Escherichia coli. II. The subunits of uridine diphosphogalactose 4-epimerase.
J. Biol. Chem.
244:2132-2136[Abstract/Free Full Text].
|
| 36.
|
Zhou, D.,
A. Zaleski,
B. Buscher,
A. Preston, and M. A. Apicella.
1996.
Presented at the Tenth International Pathogenic Neisseria Conference. Baltimore, Md
.
|
Infection and Immunity, March 1999, p. 1405-1414, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zaleski, A., Scheffler, N. K., Densen, P., Lee, F. K. N., Campagnari, A. A., Gibson, B. W., Apicella, M. A.
(2000). Lipooligosaccharide Pk (Galalpha 1-4Galbeta 1-4Glc) Epitope of Moraxella catarrhalis Is a Factor in Resistance to Bactericidal Activity Mediated by Normal Human Serum. Infect. Immun.
68: 5261-5268
[Abstract]
[Full Text]